The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Autoantibodies as potential biomarkers of immune-related adverse events in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors.
 
Aesha Gandhi
No Relationships to Disclose
 
John Taylor
No Relationships to Disclose
 
Michael Morici
No Relationships to Disclose
 
Anna Reid
No Relationships to Disclose
 
Tarek Meniawy
Honoraria - AstraZeneca/MedImmune
Consulting or Advisory Role - AstraZeneca/MedImmune; BMS; GlaxoSmithKline; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck Serono (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - BMS
 
Muhammad Adnan Khattak
No Relationships to Disclose
 
Elin Gray
Research Funding - Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - Patent - Edith cowan university (Inst)
 
Michael Millward
Consulting or Advisory Role - Amgen; BeiGene; Guardant Health; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda; The Limbic
Research Funding - Abbvie (Inst); Akeso Biopharma (Inst); Albion Laboratories (Inst); Alpine Immune Sciences (Inst); Amgen (Inst); Apollomics (Inst); AstraZeneca (Inst); AtriCure (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CStone Pharmaceuticals (Inst); Dizal Pharma (Inst); Eucure Biopharma (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Genfleet Therapeutics (Inst); GlaxoSmithKline (Inst); InventisBio (Inst); Lilly (Inst); Maxinovel (Inst); Novartis (Inst); Relay Therapeutics (Inst); Roche (Inst); Takeda (Inst); Therapim (Inst); Turning Point Therapeutics (Inst); Vivace Therapeutics (Inst); Vivace Therapeutics (Inst)
 
Pauline Zaenker
Patents, Royalties, Other Intellectual Property - Edith Cowan University (Inst)